NEW YORK (GenomeWeb News) – The Georgia Institute of Technology will partner with Saint Joseph's Hospital in Atlanta to study the genetics and cell biology involved in pancreatic cancer.

Georgia Tech said this week that the partnership involves studying tissue and serum samples with microarray technologies in order to find genetic and cellular differences between normal and tumor cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.